Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 28
Phase 33

Trial Status

Completed14

Role Distribution

Principal Investigator14
PI Rate100%

Activity Timeline

Clinical Trials (14)

NCT04343287Phase 2/3Completed
Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment
Dry Eye Syndrome
PrincipalinvestigatorStart date: 2020-01-15
NCT03334539Phase 2Completed
A Study to Assess Efficacy of HL036 in Subjects With Dry Eyes
Dry Eye
PrincipalinvestigatorStart date: 2017-11-05
NCT03198000Phase 3Completed
A Study to Evaluate the Efficacy of Investigational OTC Eye Drops
Ophthalmic Solutions
PrincipalinvestigatorStart date: 2017-06-28
NCT03097614Not ApplicableCompleted
Dry Eye Symptom Relief Assessment With Use of TrueTear in a Controlled Adverse Environment
Dry EyeDry Eye Syndromes
PrincipalinvestigatorStart date: 2017-03-31
NCT03066219Phase 2Completed
Safety and Efficacy of BRM421 for Dry Eye Syndrome
Dry Eye Syndrome
PrincipalinvestigatorStart date: 2017-02-07
NCT02970799Not ApplicableCompleted
Tear Production by Nasal Neurostimulation Compared to Active Control
Dry EyeDry Eye SyndromesKeratoconjunctivitis Sicca
PrincipalinvestigatorStart date: 2016-08-31
NCT01675570Phase 2Completed
A Study of RX-10045 in the Treatment of Dry Eye Disease
Dry Eye Syndrome
Principalinvestigator

Showing 10 of 14 trials

Research Network

Collaboration Network

15 collaborators·27 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

John Lonsdale, MD

Central Maine Eye Care

Related
2 trials

Shared therapeutic areas:

Dry EyeDry Eye Syndromes

Worked with same sponsors:

BRIM Biotechnology Inc.Mimetogen Pharmaceuticals USA, Inc.
Collaborated on 2 trials
Similarity Score28%

Stacey Ackerman, MD

Philadelphia Eye Associates

Related
3 trials

Shared therapeutic areas:

Conjunctivitis, AllergicHealthy Volunteers

Worked with same sponsors:

Nicox Ophthalmics, Inc.ORA, Inc.
Collaborated on 1 trial
Similarity Score24%

Eugene Protzko, MD

Sedeinberg Protzko Eye Associates

Related
1 trials

Shared therapeutic areas:

Healthy Volunteers

Worked with same sponsors:

Nicox Ophthalmics, Inc.ORA, Inc.
Collaborated on 1 trial
Similarity Score14%

Eugene B McLaurin, MD

Total Eye Care, PA

Related
1 trials

Shared therapeutic areas:

Dry Eye Syndromes

Worked with same sponsors:

BRIM Biotechnology Inc.
Collaborated on 1 trial
Similarity Score14%

M. Ali Haider, DO

Haider Eye Care

Related
1 trials

Shared therapeutic areas:

Healthy Volunteers

Worked with same sponsors:

Nicox Ophthalmics, Inc.ORA, Inc.
Collaborated on 1 trial
Similarity Score14%

David Wirta, MD

Eye Research Foundation

Related
3 trials

Shared therapeutic areas:

Dry Eye Syndromes

Worked with same sponsors:

BRIM Biotechnology Inc.
Collaborated on 1 trial
Similarity Score14%

Ranjan Malhotra, MD

Ophthalmology Associates

Related
1 trials

Shared therapeutic areas:

Healthy Volunteers

Worked with same sponsors:

Nicox Ophthalmics, Inc.ORA, Inc.
Collaborated on 1 trial
Similarity Score14%

Robert Rice, MD

R&R Eye Research

Related
1 trials

Shared therapeutic areas:

Healthy Volunteers

Worked with same sponsors:

Nicox Ophthalmics, Inc.ORA, Inc.
Collaborated on 1 trial
Similarity Score14%

Blair Boehmer, MD

Midwest Cornea Associates, LLC.

Related
1 trials

Shared therapeutic areas:

Dry Eye Syndromes

Worked with same sponsors:

BRIM Biotechnology Inc.
Collaborated on 1 trial
Similarity Score14%

Tim McNamara, PharmD

ISTA Pharmaceuticals, Inc.

Related
17 trials

Shared therapeutic areas:

Dry Eye SyndromesConjunctivitis, Allergic
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (14)

Showing 14 of 14 trials

NCT04343287Phase 2/3PrincipalInvestigator

Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment

Dry Eye Syndrome
Completed
NCT03334539Phase 2PrincipalInvestigator

A Study to Assess Efficacy of HL036 in Subjects With Dry Eyes

Dry Eye
Completed
NCT03198000Phase 3PrincipalInvestigator

A Study to Evaluate the Efficacy of Investigational OTC Eye Drops

Ophthalmic Solutions
Completed
NCT03201562Phase 2PrincipalInvestigator

A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia

Presbyopia
Completed
NCT03097614Not ApplicablePrincipalInvestigator

Dry Eye Symptom Relief Assessment With Use of TrueTear in a Controlled Adverse Environment

Dry EyeDry Eye Syndromes
Completed
NCT03066219Phase 2PrincipalInvestigator

Safety and Efficacy of BRM421 for Dry Eye Syndrome

Dry Eye Syndrome
Completed
NCT02970799Not ApplicablePrincipalInvestigator

Tear Production by Nasal Neurostimulation Compared to Active Control

Dry EyeDry Eye SyndromesKeratoconjunctivitis Sicca
Completed
NCT01257607Phase 2PrincipalInvestigator

Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye

Dry Eye
Completed
NCT01639846Phase 2PrincipalInvestigator

Evaluation of the Onset and Duration of Action of RX-10045 in Allergic Conjunctivitis

Allergic Conjunctivitis
Completed
NCT01675570Phase 2PrincipalInvestigator

A Study of RX-10045 in the Treatment of Dry Eye Disease

Dry Eye Syndrome
Completed
NCT01733992Phase 1PrincipalInvestigator

A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease

Keratoconjunctivitis Sicca
Completed
NCT02235259Phase 2PrincipalInvestigator

Efficacy and Safety of XG-104 for the Treatment of Dry Eye

Dry Eye
Completed
NCT02276638PrincipalInvestigator

Comparative Study of Specular Microscopes for Measurements of Cell Density, Coefficient of Variation and Hexagonality

Corneal Endothelial Cell Loss
Completed
NCT02756624Phase 3PrincipalInvestigator

A Multi-Center, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution

Healthy Subjects
Completed

All 14 trials loaded